Obesity

Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome

The treatment combines Clearmind’s MEAI, a novel proprietary psychedelic treatment for various addictions, and…

Ryan has been a financial writer for more than a decade, covering…

Aduro Clean Technologies, Inc. (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5) CEO Ofer…

Sometimes stock market performance doesn’t line up with the fundamentals of a…

D. Boral Capital is a premier global investment bank headquartered in New…

Major technological advances are often driven by market demand for solutions to…